Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 152

Results For "bio"

4177 News Found

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
Drug Approval | April 23, 2026

Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA

The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling


AbbVie bets $1.4B on North Carolina pharma mega-campus
News | April 23, 2026

AbbVie bets $1.4B on North Carolina pharma mega-campus

Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing


India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation
News | April 23, 2026

India’s nutraceutical market sees entry of quantum-enhanced curcumin formulation

New formulation by Greenspace Herbs to target improved efficacy and lower dosage in curcumin supplements


Japanese pharma firms turn to CDMOs early as peptide complexity rises
News | April 23, 2026

Japanese pharma firms turn to CDMOs early as peptide complexity rises

Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages


Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
R&D | April 22, 2026

Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies

Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research


Blueneem Medical Devices  appoints Manoj Tumkur Venkatachala as Chief Product Officer
People | April 22, 2026

Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer

Manoj has over two decades of experience in healthcare operations and biomedical engineering


India–UK life sciences research to advance through new cross-border innovation corridor
R&D | April 22, 2026

India–UK life sciences research to advance through new cross-border innovation corridor

C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration


New guardian protein mechanism identified in aggressive skin cancer progression
R&D | April 22, 2026

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies


Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
Biopharma | April 22, 2026

Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push

The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform